The novel approach of tirzepatide peptide represents a significant advance in the handling of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide901326.aioblogs.com/94738948/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment